Abbott Laboratories (ABT)vsAlphatec Holdings Inc (ATEC)
ABT
Abbott Laboratories
$104.83
+0.74%
HEALTHCARE · Cap: $180.82B
ATEC
Alphatec Holdings Inc
$11.49
-2.21%
HEALTHCARE · Cap: $1.74B
Smart Verdict
WallStSmart Research — data-driven comparison
Abbott Laboratories generates 5701% more annual revenue ($44.33B vs $764.15M). ABT leads profitability with a 14.7% profit margin vs -18.8%. ATEC appears more attractively valued with a PEG of 0.48. ABT earns a higher WallStSmart Score of 51/100 (C-).
ABT
Buy51
out of 100
Grade: C-
ATEC
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-315.5%
Fair Value
$25.23
Current Price
$104.83
$79.60 premium
Intrinsic value data unavailable for ATEC.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Strong operational efficiency at 21.6%
Generating 2.6B in free cash flow
Growing faster than its price suggests
Revenue surging 20.4% year-over-year
Areas to Watch
Expensive relative to growth rate
Moderate valuation
4.4% revenue growth
Weak financial health signals
0.0% earnings growth
Smaller company, higher risk/reward
Trading at 143.6x book value
ROE of -6.3% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : ABT
The strongest argument for ABT centers on Market Cap, Operating Margin, Free Cash Flow.
Bull Case : ATEC
The strongest argument for ATEC centers on PEG Ratio, Revenue Growth. Revenue growth of 20.4% demonstrates continued momentum. PEG of 0.48 suggests the stock is reasonably priced for its growth.
Bear Case : ABT
The primary concerns for ABT are PEG Ratio, P/E Ratio, Revenue Growth.
Bear Case : ATEC
The primary concerns for ATEC are EPS Growth, Market Cap, Price/Book.
Key Dynamics to Monitor
ABT profiles as a value stock while ATEC is a growth play — different risk/reward profiles.
ATEC carries more volatility with a beta of 1.04 — expect wider price swings.
ATEC is growing revenue faster at 20.4% — sustainability is the question.
ABT generates stronger free cash flow (2.6B), providing more financial flexibility.
Bottom Line
ABT scores higher overall (51/100 vs 41/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Abbott Laboratories
HEALTHCARE · MEDICAL DEVICES · USA
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Visit Website →Alphatec Holdings Inc
HEALTHCARE · MEDICAL DEVICES · USA
Alphatec Holdings, Inc., a medical technology company, designs, develops and advances technologies for the surgical treatment of spinal disorders. The company is headquartered in Carlsbad, California.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?